BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22438506)

  • 1. Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec.
    Cerigo H; Coutlée F; Franco EL; Brassard P
    J Med Screen; 2012 Mar; 19(1):42-8. PubMed ID: 22438506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
    Chatzistamatiou K; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Skenderi A; Stamatopoulos K; Agorastos T
    Gynecol Oncol; 2021 Sep; 162(3):560-568. PubMed ID: 34210517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
    Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of self-collected versus clinician collected cervicovaginal specimens for detection of high risk human papillomavirus among HIV infected women in Ethiopia.
    Bogale AL; Teklehaymanot T; Ali JH; Kassie GM; Medhin G; Baye AY; Shiferaw AY
    BMC Womens Health; 2022 Sep; 22(1):360. PubMed ID: 36050660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel.
    Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
    Int J Cancer; 2019 Jan; 144(1):89-97. PubMed ID: 29943822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens.
    Khanna N; Mishra SI; Tian G; Tan MT; Arnold S; Lee C; Ramachandran S; Bell L; Baquet CR; Lorincz A
    Int J Gynecol Cancer; 2007; 17(3):615-22. PubMed ID: 17504376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
    Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
    J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
    Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
    PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.
    Geraets DT; van Baars R; Alonso I; Ordi J; Torné A; Melchers WJ; Meijer CJ; Quint WG
    J Clin Virol; 2013 Jun; 57(2):125-9. PubMed ID: 23518442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
    Gyllensten U; Sanner K; Gustavsson I; Lindell M; Wikström I; Wilander E
    Br J Cancer; 2011 Aug; 105(5):694-7. PubMed ID: 21811250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens.
    Guan Y; Gravitt PE; Howard R; Eby YJ; Wang S; Li B; Feng C; Qiao YL; Castle PE
    J Virol Methods; 2013 Apr; 189(1):167-71. PubMed ID: 23370404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
    Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
    Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
    Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
    J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical Human Papillomavirus Testing With Two Home Self-Collection Methods Compared With a Standard Clinically Collected Sampling Method.
    McLarty JW; Williams DL; Loyd S; Hagensee ME
    Sex Transm Dis; 2019 Oct; 46(10):670-675. PubMed ID: 31517806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda.
    Safaeian M; Kiddugavu M; Gravitt PE; Ssekasanvu J; Murokora D; Sklar M; Serwadda D; Wawer MJ; Shah KV; Gray R
    Sex Transm Dis; 2007 Jul; 34(7):429-36. PubMed ID: 17075437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness and knowledge about human papillomavirus among Inuit women in Nunavik, Quebec.
    Cerigo H; Macdonald ME; Franco EL; Brassard P
    J Community Health; 2011 Feb; 36(1):56-62. PubMed ID: 20517640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility.
    Ajenifuja OK; Ikeri NZ; Adeteye OV; Banjo AA
    Pan Afr Med J; 2018; 30():110. PubMed ID: 30364362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Assessment of a Self-sampling Device and Gynecologist Sampling for Cytology and HPV DNA Detection in a Rural and Low Resource Setting: Malaysian Experience.
    Latiff LA; Ibrahim Z; Pei CP; Rahman SA; Akhtari-Zavare M
    Asian Pac J Cancer Prev; 2015; 16(18):8495-501. PubMed ID: 26745108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.